Related Experiment Video
Updated: Jan 11, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
2024 annual report on cardiovascular health and diseases in China: Data and trend
Mingbo Liu1, Xinye He, Xiaohong Yang
1National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China.
Insights
Cardiovascular diseases (CVD) are a major public health concern in China, with high incidence and mortality rates. This study analyzes CVD trends and risk factors to inform prevention and policy.
Area of Science:
- Public Health
- Epidemiology
- Cardiovascular Medicine
Background:
- Cardiovascular diseases (CVD) pose a significant and growing threat to public health globally and in China.
- Recent data highlights the substantial burden of CVD, including acute myocardial infarction (AMI) and stroke, on the Chinese population.
Purpose of the Study:
- To analyze the latest incidence and mortality data for cardiovascular diseases in China.
- To provide an updated assessment of key risk factors associated with CVD.
- To inform public health policy and guide CVD prevention and control strategies.
Main Methods:
- Analysis of data from the 2024 Annual Report on Cardiovascular Health and Diseases in China.
- Review of incidence and mortality rates for various CVDs and their subtypes.
- Compilation and examination of data on prevalent CVD risk factors.
Main Results:
- The crude incidence of CVD and cerebrovascular diseases was 620.33 per 100,000 population, with stroke at 491.0 and AMI at 87.6.
- CVD mortality in 2021 was 364.16 per 100,000 in rural and 305.39 per 100,000 in urban areas.
- Prevalence of adult coronary heart disease (CHD) was 758 per 100,000, with higher mortality in rural areas.
Conclusions:
- CVD remains the leading cause of death in China, necessitating urgent public health interventions.
- Understanding the trends in CVD incidence, mortality, and risk factors is crucial for effective prevention.
- This data provides a scientific basis for developing targeted policies to combat the growing CVD epidemic.
Abstract:
The incidence of cardiovascular diseases (CVD) together with their associated risk factors increasingly impact public health. According to the data provided in the 2024 Annual Report on Cardiovascular Health and Diseases in China, the crude incidence of cardiovascular and cerebrovascular diseases among Chinese residents aged ≥18 years, including acute myocardial infarction (AMI), angina pectoris treated by percutaneous transluminal coronary angioplasty/stent implantation and/or coronary artery bypass grafting, stroke, and sudden cardiac death was 620.33 per 100,000 population, with 87.6 for AMI. Stroke had an incidence of 491.0 per 100,000 population. The prevalence of adult coronary heart disease (CHD, aged ≥18 years) was 758 per 100,000 population. The CVD mortality in 2021 remained the highest, exceeding that of cancer and other causes. The crude mortality rate of CVD in 2021 was 364.16 per 100,000 population in rural areas and 305.39 per 100,000 population in urban areas. The crude mortality rates of cerebrovascular diseases and CHD among urban and rural residents in 2021 were 140.02 and 175.58, 135.08 and 148.19 per 100,000 population, respectively. In addition to interpreting the key findings of CVD incidence and mortality in China, we also update the data of associated risk factors, including tobacco use, physical activity, diet and nutrition, overweight and obesity, hypertension, dyslipidemia, diabetes, chronic kidney disease, sleep and psychological factors, environmental factors, and the diagnostic conditions of CVD diseases, aiming to provide a scientific foundation for advancing CVD prevention and control, and to inform relevant public health policy development.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease IV: Preventive Measures
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...